Standard BioTools Inc. (LAB) vs TriSalus Life Sciences, Inc. (TLSI)
A side-by-side comparison of Standard BioTools Inc. and TriSalus Life Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LAB
Standard BioTools Inc.
$0.72HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TLSI
TriSalus Life Sciences, Inc.
$4.27HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LAB vs TLSI
growth of $100 · dividends reinvested · last 6yLAB -88.3% (-30.1%/yr)TLSI -58.4% (-13.6%/yr)TLSI compounded faster over this window
LAB TLSI
LAB vs TLSI: by the numbers
- •LAB is the larger company ($283M vs $263M market cap).
- •Both run net losses; TLSI's is the smaller (-62.59% vs -103.29% net margin).
Metrics side by side
Valuation
| Metric | LAB | TLSI |
|---|---|---|
| P/S ratio | 3.34 | 5.83 |
| P/B ratio | 0.52 | 40.14 |
Profitability
| Metric | LAB | TLSI |
|---|---|---|
| Gross margin | 49.14% | 85.79% |
| Operating margin | -109.34% | -59.68% |
| Net margin | -103.29% | -62.59% |
| ROE | -16.18% | -430.72% |
| ROIC | -14.06% | -59.50% |
Growth (annualized)
| Metric | LAB | TLSI |
|---|---|---|
| Revenue CAGR (5Y) | -10.62% | N/A |
| Total return CAGR (5Y) | -32.98% | -15.05% |
Frequently asked
- How have LAB and TLSI total returns compared?
- Over the past 5 years, LAB delivered -32.98% and TLSI delivered -15.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.